The expression levels of TβRII in patients with lymph node metastasis were significantly higher compared with patients without lymph node metastasis, and a statistically significant difference was observed between the two groups (P = 0.033). Here, TGFBR2 is linked to metastatic malignant neoplasm in the lymph nodes.